Active Psoriatic arthritis Completed Phase 2 Trials for Ustekinumab (DB05679)

Also known as: Psoriatic arthritis aggravated / Psoriatic arthropathy aggravated / Psoriatic arthropathy NOS (disorder) / Psoriatic arthropathy / Arthropathy psoriatic / Psoriatic arthritis / Psoriasis with arthropathy (disorder) / Arthritis, Psoriatic / Psoriatic arthropathies / Arthropathic psoriasis / Arthropathic psoriasis, unspecified

IndicationStatusPhase
DBCOND0020384 (Active Psoriatic arthritis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03881059Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)Treatment